Baird Financial Group Inc. boosted its stake in InMode Ltd. (NASDAQ:INMD – Get Rating) by 53.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,695 shares of the healthcare company’s stock after acquiring an additional 6,822 shares during the period. Baird Financial Group Inc.’s holdings in InMode were worth $441,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the stock. Renaissance Technologies LLC raised its holdings in InMode by 23.2% in the first quarter. Renaissance Technologies LLC now owns 3,181,662 shares of the healthcare company’s stock worth $117,435,000 after purchasing an additional 598,300 shares in the last quarter. William Blair Investment Management LLC lifted its position in InMode by 16.4% during the 1st quarter. William Blair Investment Management LLC now owns 1,925,527 shares of the healthcare company’s stock valued at $71,071,000 after acquiring an additional 271,606 shares during the period. Meitav Dash Investments Ltd. lifted its position in InMode by 45.3% during the 2nd quarter. Meitav Dash Investments Ltd. now owns 1,433,785 shares of the healthcare company’s stock valued at $32,255,000 after acquiring an additional 447,075 shares during the period. State Street Corp boosted its stake in InMode by 12.4% during the first quarter. State Street Corp now owns 869,820 shares of the healthcare company’s stock worth $32,105,000 after acquiring an additional 95,985 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. grew its holdings in InMode by 14.8% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 663,692 shares of the healthcare company’s stock worth $14,873,000 after purchasing an additional 85,796 shares during the period. 54.93% of the stock is owned by hedge funds and other institutional investors.
InMode Trading Down 1.9 %
InMode stock opened at $35.41 on Tuesday. InMode Ltd. has a 12 month low of $20.60 and a 12 month high of $89.93. The stock has a fifty day simple moving average of $32.72 and a two-hundred day simple moving average of $29.60. The firm has a market cap of $2.95 billion, a price-to-earnings ratio of 17.11 and a beta of 2.21.
Analyst Ratings Changes
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
- Get a free copy of the StockNews.com research report on InMode (INMD)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Is Ardelyx is A Buy After Slip in Early 2022
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.